Form 4: Clearside Biomedical Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Benjamin R. Yerxa purchased 7,813 shares of Clearside Biomedical, Inc. at $1.31 per share on May 15, 2024.
Summary
- On May 15, 2024, Benjamin R. Yerxa, a director of Clearside Biomedical, Inc. (CLSD), acquired 7,813 shares of common stock at a price of $1.31 per share.
- Following the transaction, Yerxa directly owns 17,957 shares of Clearside Biomedical.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the transaction is relatively small and doesn't provide a strong signal.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of stock acquisition by Benjamin R. Yerxa |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.